Nebracetam
From Wikipedia, the free encyclopedia
 |
The topic of this article may not meet Wikipedia's general notability guideline. (May 2015) (Learn how and when to remove this template message) |
 |
This article relies largely or entirely upon a single source. (June 2015) |
 |
|
 |
|
| Clinical data | |
|---|---|
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
|
|
| CAS Number | 97205-34-0  |
| PubChem (CID) | 65926 |
| ChemSpider | 59334 |
| UNII | T30038QI8N |
| ChEMBL | CHEMBL2104682 |
| Chemical and physical data | |
| Formula | C12H16N2O |
| Molar mass | 204.268 g/mol |
| 3D model (Jmol) | Interactive image |
| Chirality | Racemic mixture |
|
|
|
|
| (verify) | |
Nebracetam is an investigational drug of the racetam family that is a M1 acetylcholine receptor agonist in rats.[1] Its effects in humans have not been studied.
See also[edit]
References[edit]
- ^ Takeo, S.; Hayashi, H.; Miyake, K.; Takagi, K.; Tadokoro, M.; Takagi, N.; Oshikawa, S. (1997). "Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats". British Journal of Pharmacology. 121 (3): 477–484. doi:10.1038/sj.bjp.0701161. PMC 1564714
. PMID 9179389.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
